Related Experiment Video
Updated: Jul 17, 2026

Spectral Karyotyping to Study Chromosome Abnormalities in Humans and Mice with Polycystic Kidney Disease
Published on: February 3, 2012
Beta-catenin signaling: linking renal cell carcinoma and polycystic kidney disease
Benedetta Peruzzi1, Donald P Bottaro
1Urologic Oncology Branch, CCR, NCI, Bethesda, Maryland 20892-1107, USA.
Abstract:
Loss of von Hippel-Lindau (VHL) tumor suppressor gene function occurs in familial and most sporadic renal cell carcinoma (RCC), resulting in the aberrant expression of genes that control cell proliferation, invasion and angiogenesis. The molecular mechanisms by which VHL loss leads to tumorigenesis are not yet fully defined. The VHL gene product, pVHL, is part of an E3 ubiquitin ligase complex that targets hypoxia inducible factors for polyubiquitination and proteosomal degradation, implicating hypoxia response genes in RCC oncogenesis. VHL loss also allows robust RCC cell invasiveness and morphogenesis in response to hepatocyte growth factor (HGF), an important regulator of kidney development and renal homeostasis. Recent elucidation of the mechanism by which pVHL represses developmental HGF responses in adult kidney has identified another oncogenically relevant E3 ligase target: beta-catenin. This discovery also further unifies recent insights into the molecular pathogenesis of polycystic kidney disease, where the identification of disease genes has revealed the integration of signaling pathways associated with primary cilia function and the regulation of cell growth and differentiation.
Insights
Loss of the von Hippel-Lindau (VHL) tumor suppressor gene drives renal cell carcinoma (RCC) by affecting hypoxia response and cell growth pathways. This involves aberrant regulation of beta-catenin and hepatocyte growth factor signaling.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Loss of the von Hippel-Lindau (VHL) tumor suppressor gene is a key event in familial and sporadic renal cell carcinoma (RCC).
- The precise molecular mechanisms linking VHL loss to tumorigenesis, including aberrant gene expression controlling proliferation, invasion, and angiogenesis, are under investigation.
- pVHL, the VHL gene product, functions within an E3 ubiquitin ligase complex targeting hypoxia-inducible factors for degradation, suggesting a role for hypoxia response pathways in RCC.
Purpose of the Study:
- To elucidate the molecular mechanisms by which VHL loss contributes to renal cell carcinoma (RCC) oncogenesis.
- To investigate the role of VHL in repressing developmental hepatocyte growth factor (HGF) responses in the adult kidney.
- To explore the connection between VHL, beta-catenin, and the pathogenesis of polycystic kidney disease.
Main Methods:
- Analysis of the E3 ubiquitin ligase complex activity of pVHL.
- Investigating the degradation targets of the VHL-containing E3 ligase complex, including hypoxia-inducible factors and beta-catenin.
- Studying the impact of VHL loss on renal cell carcinoma cell invasiveness and morphogenesis in response to HGF.
Main Results:
- VHL loss results in the aberrant expression of genes involved in cell proliferation, invasion, and angiogenesis.
- pVHL targets hypoxia-inducible factors for proteasomal degradation, implicating hypoxia response genes in RCC.
- pVHL represses developmental HGF responses in the adult kidney by targeting beta-catenin, linking VHL to HGF signaling and RCC pathogenesis.
Conclusions:
- VHL loss is a critical driver of renal cell carcinoma through dysregulation of hypoxia response and HGF signaling pathways.
- The identification of beta-catenin as an E3 ligase target further unifies understanding of VHL's role in RCC and polycystic kidney disease.
- Understanding these molecular pathways provides insights into kidney development, homeostasis, and oncogenesis.
Related Concept Videos
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Microtubules in Signaling
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Chronic Kidney Disease I: Introduction
Nephrons
